Long-term acute care hospital closures may have unintended consequences for patient care

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

Al­giax Phar­ma­ceu­ti­cals’ non-opi­oid can­di­date has achieved “clin­i­cal­ly mean­ing­ful” pain re­duc­tion in a mid-stage tri­al of peo­ple with pe­riph­er­al post-sur­gi­cal neu­ro­path­ic pain, mark­ing an­oth­er suc­cess in